Physician profile
Henrik Slots
NPI 1679899892
$4,849.91
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,964 · 2022: $1,884 · 2023: $1,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,000.83 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,059.18 | 2021-2023 | Vraylar, Qulipta, Ubrelvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $441.73 | 2021-2023 | Jardiance |
| Novo Nordisk INC | $422.93 | 2021-2023 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $338.22 | 2021-2023 | Farxiga |
| Pfizer INC. | $324.37 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $218.40 | 2021-2023 | Belsomra, Steglatro, Pneumovax 23 |
| Glaxosmithkline, LLC. | $166.10 | 2021-2023 | Trelegy Ellipta |
| Lilly USA, LLC | $148.92 | 2021-2023 | Jardiance, Emgality, Trulicity |
| Edwards Lifesciences Corporation | $145.67 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Biohaven Pharmaceuticals, INC. | $139.88 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $138.72 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $130.48 | 2021-2023 | Xifaxan |
| Amgen INC. | $126.18 | 2021-2023 | Evenity, Prolia |
| Corcept Therapeutics | $114.75 | 2021-2023 | Korlym |
| Astellas Pharma US INC | $104.16 | 2021-2023 | Veozah |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $93.70 | 2022 | |
| Sanofi-Aventis U.S. LLC | $90.50 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $71.11 | 2022-2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $70.06 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $66.28 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $59.74 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $56.78 | 2021-2022 | |
| Clarus Therapeutics INC. | $45.65 | 2021 | |
| Sanofi Pasteur INC. | $40.78 | 2021-2023 | |
| Eisai INC. | $35.68 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.05 | 2021-2022 | |
| Esperion Therapeutics, INC. | $32.16 | 2022-2023 | Nexletol |
| Ironwood Pharmaceuticals, INC | $26.96 | 2021 | |
| Sunovion Pharmaceuticals INC. | $23.01 | 2021 | |
| Supernus Pharmaceuticals, INC. | $20.98 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.69 | 2022 | |
| Exact Sciences Corporation | $15.21 | 2023 | Cologuard Collection Kit |
| Uswm, LLC | $15.08 | 2021 | |
| Alnylam Pharmaceuticals INC. | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henrik Slots listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.